
Sign up to save your podcasts
Or


New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)
By BBC Radio 44.7
3232 ratings
New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)

7,837 Listeners

374 Listeners

892 Listeners

1,071 Listeners

55 Listeners

41 Listeners

5,503 Listeners

1,803 Listeners

1,887 Listeners

1,067 Listeners

2,126 Listeners

1,980 Listeners

719 Listeners

58 Listeners

239 Listeners

68 Listeners

104 Listeners

669 Listeners

157 Listeners

3,212 Listeners

1,601 Listeners

3,405 Listeners

789 Listeners

195 Listeners

58 Listeners